27 de noviembre de 2026
FDA PDUFA target action date for BBP-418, a NDA from BridgeBio Pharma. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.
Calendario de Fechas de decisión PDUFA de la FDA